Biotest exhibited at the 87th China International Medical Equipment Fair (CMEF) 2023, which was held at the Shanghai National Exhibition and Convention Center from May 13 to 17, 2023.

The 87th CMEF is an event where cutting-edge technology and forward-looking academics meet. Nearly 5,000 exhibitors from the whole industry chain at home and abroad presented tens of thousands of sophisticated products on the same stage, and thousands of new products were launched on site, making it a dazzling event. The exhibition is an event for sharing unlimited business opportunities and global exploration. More than 220,000 industry visitors, including various medical institutions and distribution agents around the world, were present for business exchanges and cooperation negotiations.

 

 

In this event, Biotest brings a number of key products for domestic and international markets, among which the products of great interest are infectious disease, preoperative four test combo,  ABO positive type and RhD blood group detection reagents, ABO positive type blood group detection reagents, microfluidic fluorescence immunoassay analyzer and reagents, pet detection reagents, newly pronounced cups of drug of abuse, etc.

 

 

 

During the exhibition, Biotest communicated deeply with many domestic and foreign distributors and professionals to analyze the focal and difficult issues of the in vitro testing terminal market and to seek a new direction for the healthy development of the in vitro diagnostic industry.

 

As a company focusing on the research and development of in vitro diagnostic reagents, Biotest is committed to improving user experience and product quality to provide a better diagnostic experience for doctors and patients. Looking ahead, we will continue to uphold the concept of "building an excellent Chinese national diagnostic brand", continuously innovate and expand business areas, actively explore domestic and international markets, and achieve sustainable development of the enterprise.

Finally, thank you again for your support and trust, Shanghai CMEF exhibition ended successfully, let's work together to create a better future, look forward to meeting again in Nanchang CALCP exhibition!

 

 

 

About Biotest：

Founded in 2008, Biotest is a national high-tech enterprise specializing in the research, development, manufacture, sales and service of in vitro diagnostic reagents, raw materials and instruments. Biotest is committed to providing innovative, real-time, high-quality diagnostic products and solutions to users around the world to meet the unfinished medical needs.

Biotest has five series, including infectious disease, drug abuse, tumor marker, cardiac marker and woman’s health, which are widely used in hospitals at all levels, CDC, blood stations, drug rehabilitation and third-party inspection institutions. The company has passed the German TUV ISO13485 quality system certification, and many products have NMPA registration in China, CE certification in EU and FDA 510(k) certificate in USA.

Biotest pays attention to the independent research and development of products and technology accumulation. The company has industrialized technology platforms such as rapid immunodiagnosis platform, POCT application technology platform, biological core raw material technology platform and automatic production technology platform, and provides enterprises with a number of patented technologies and the development and production of innovative products every year. The company has a marketing team with rich sales management experience to provide complete professional services for end customers and distributors.